Shop by goal
Popular compounds
Research resources
Recently viewed
Growth-Hormone Research Peptides
Growth-hormone secretagogue research compounds from both receptor classes studied in pituitary release models: GHRH analogues that act at the GHRH receptor, and ghrelin-receptor (GHS-R1a) agonists that act at a separate site. Half-life is the main practical difference within each class, from minutes to several days. Supplied for laboratory research only.
Lower price per vial than single vials
Research Compounds
Create a Pack of Vials
Mix any eligible single vials into one pack of your own.
Ipamorelin
★★★★★ ★★★★★ 4.5 4 reviews
(Selective GH-Releasing Pentapeptide)
Ipamorelin is a five-amino-acid growth-hormone secretagogue that acts at the ghrelin receptor GHS-R1a. Investigated for pituitary GH-release signalling and receptor selectivity in endocrine research.
Tesamorelin
★★★★★ ★★★★★ 4.3 14 reviews
(Stabilised GHRH 1-44 Analog)
Tesamorelin is a stabilised growth-hormone-releasing hormone analogue based on GHRH(1-44). Relevant research examines GHRH-receptor activation, pituitary growth-hormone release and GH/IGF-1 endocrine signalling.
CJC-1295 (no DAC)
(Modified GRF 1-29, Mod GRF)
CJC-1295 without DAC is a modified GRF(1-29) analogue lacking the albumin-binding drug affinity complex. Studied for GHRH-receptor activity and short-duration growth-hormone-axis signalling.
CJC-1295 (with DAC)
(Modified GRF 1-29 with Drug Affinity Complex)
CJC-1295 with DAC is a modified GHRH analogue containing an albumin-binding drug affinity complex. Research compares prolonged GHRH-receptor signalling with shorter-acting GRF analogues.
Sermorelin
(GHRH 1-29 / Growth Hormone-Releasing Factor)
Sermorelin is the N-terminal 29-amino-acid fragment of growth-hormone-releasing hormone. Used in endocrine research examining GHRH-receptor activation and pulsatile pituitary GH signalling.
Hexarelin
★★★★★ ★★★★★ 5 1 review
(Examorelin, MF-6003)
Hexarelin is a synthetic growth-hormone-releasing hexapeptide and ghrelin-receptor agonist. Investigated in endocrine studies of GH release and receptor interactions, including GHS-R1a and CD36.
GHRP-2
(Pralmorelin, KP-102)
GHRP-2 (pralmorelin) is a synthetic hexapeptide agonist of the ghrelin receptor. Studied in endocrine research for growth-hormone secretagogue activity and related hypothalamic-pituitary pathways.
GHRP-6
(Growth Hormone Releasing Hexapeptide)
GHRP-6 is a synthetic growth-hormone-releasing hexapeptide that activates the ghrelin receptor. Investigated in GH-secretion and ghrelin-receptor signalling models.
What you will find here
Sermorelin is GHRH(1-29). CJC-1295 without DAC (Mod GRF 1-29) carries four amino-acid substitutions, including D-Ala2 for DPP-IV resistance. CJC-1295 with DAC carries a Drug Affinity Complex that binds albumin, extending its half-life to roughly a week. Tesamorelin is a GHRH(1-44) analogue with an N-terminal hexenoic-acid group. On the ghrelin-receptor side, ipamorelin is studied as a selective GHS-R1a agonist. GHRP-2 and GHRP-6 are hexapeptide GHS-R1a agonists. Hexarelin, a related hexapeptide, also binds the CD36 receptor. Because the two classes act at different receptors, published models often pair one GHRH analogue with one ghrelin-receptor agonist, and each product page states the strengths available.
Research guides: GH-Axis Research
Added to cart
Explore New-U
Research tools and resources
Browse the catalogue, review the research library or use New-U’s free research tools.
PRECISION. PURITY. PERFORMANCE.
Research peptides. Third-party Certificates of Analysis (Janoshik Analytical & Freedom Diagnostics) are published on the website. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Research use only - all claims made on this site are for testing and research use only. Purchasers must be 21 years of age or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
Principal office: 1712 Pioneer Ave., Ste. 500, Cheyenne, WY 82001, USA
© 2026 New-U Research Compounds · new-u.io
[image: Ipamorelin research peptide vial - growth hormone compound]
[image: Tesamorelin research peptide vial - growth hormone compound]
[image: CJC-1295 (no DAC) research peptide vial - growth hormone compound]
[image: CJC-1295 research peptide vial - growth hormone compound]
[image: Sermorelin research peptide vial - growth hormone compound]
[image: Hexarelin research peptide vial - growth hormone compound]
[image: GHRP-2 research peptide vial - growth hormone compound]
[image: GHRP-6 research peptide vial - growth hormone compound]
[image: New-U Research Compounds on PepFinder, PepFinder rating 8.9 out of 10, store checked]
[image: Verified by Metrix]